Iterative Scopes today announced a partnership to bring its AI recruitment (AIR) technology to One GI’s clinical research.
The partnership stipulates that, initially, One GI uses AIR at its Gastro One clinical research site in Memphis, Tennessee. It then plans to expand to additional research sites within the One GI network.
Cambridge, Massachusetts-based Iterative Scopes said implementing AIR aids in the recruitment of patients for clinical trials. Those trials focus on inflammatory bowel disease (IBD).
One GI, a gastroenterology management services organization (MSO), has 40 sites within its network. That spans across Tennessee, Mississippi, Kentucky, Ohio, and Indiana.
The partnership allows One GI physicians to leverage Iterative Scopes’ AI-based technology. It enables the standardization of the endoscopic scoring process for patients. This also helps helps to identify potentially eligible IBD patients to enroll in trials. Iterativ…